Braveheart Bio, Inc.

BRVE

Insiders bought in the last twelve months.

18.71 0.84 −4.30%
Market cap
$1.8B
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Jun '25
ROE
0.00% — — —
ROA
0.00% — — —
ROIC
0.00% 0.00% 0.00% —
Return on Tangible Assets
(29.16%) 0.00% 0.00% —
Free Cash Flow per Share
(2.99) 0.00 — 0.00
Free Cash Flow
(22.14) — — —
Other line items
Cash ROIC
(81.61%) 0.00% 0.00% —
Average Days of Payables
0.00 0.00 0.00 —
Tax Rate
0.00 — — —
Selling, General and Administrative Expense of Revenue
0.00% — — —
Operating CF/Net income
0.66 — — —
Depreciation/Fixed assets
0.00 0.00 — —
Revenue per Share
0.00 0.00 — 0.00
Operating CF per Share
(2.99) 0.00 — 0.00
Capex per Share
0.00 0.00 — 0.00

Fold the line items

Columns are period end dates · fundamentals updated 1 Oct 2026